6:28 PM
 | 
Oct 18, 2012
 |  BC Extra  |  Financial News

ImmunoCellular adds $21M

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC) raised $21 million through the sale of 10 million shares at $2.10 in a follow-on underwritten by...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >